Thus, given these changes in expression AKt, Caspase 9 and Bax, we presume that the initiation of the observed apoptosis by the engineered MNPs may occur via the PI3K/AKT pathway that is known as the main pathway involved in breast cancer. This evidence concerns the gene CASP9 and breast carcinoma.